Seamless Phase I/II Adaptive Design for Oncology Trials of Molecularly Targeted Agents (Q133806)

From MaRDI portal
Revision as of 11:58, 24 April 2023 by Importer (talk | contribs) (‎Created a new Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
Seamless Phase I/II Adaptive Design for Oncology Trials of Molecularly Targeted Agents
scientific article

    Statements

    25
    0 references
    5
    0 references
    903-920
    0 references
    6 June 2014
    0 references
    0 references
    0 references